Atlas Trials

A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure

Clinical trial NCT02012075 · UNKNOWN

Trial details

NCT number
NCT02012075
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure
Start date
2013-12-01
Primary completion
2015-02-01
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.